In 2014, Prolira participated in the Venture Challenge as a start-up. Now, years later, the announcement has been made that several parties together invest €5 million in the scale-up to further help hospital departments improve patient care in the field of acute brain failure (acute encephalopathy and delirium).
Are you the next emerging biotech entrepreneur in the Netherlands? And do you want access to experienced life science mentors, networking with fellow peer entrepreneurs and do you want to have an inside look in the Massachusetts life sciences sector?
Venture Challenge alumnus River BioMedics, a drug discovery company using advanced 3D human cardiac models, today announced the closure of a 1.8 million Euro seed funding round to progress its pipeline of cardiovascular disease targets and compounds
Pivotal study published in Nutrients showing that Nutrileads’ proprietary carrot-derived rhamnogalacturonan-I (cRG-I) (commercially known as BeniCaros) fiber, accelerates protective anti-viral immune responses and reduces symptoms after an exper
Venture Challenge alumnus Incircular was one of the 42 projects that received a EIC transition grant in the first ever round of this new scheme to support projects to take breakthrough technologies from the lab into the real world.
San Fransisco / Eindhoven – Ambagon Therapeutics, a biotechnology company unlocking intrinsically disordered proteins and other difficult-to-target protein classes, today announced an $85 million Series A to augment its
Venture Challenge Winner SeraNovo is pleased to announce the closing of a second license agreement with Graviton Bioscience Corporation (Graviton), a biopharmaceutical company engaged in the research and development of small molecules in the fields of oncol